| 1/170 | US=84 / Tese/FAP Nishimoto IN. Biomarcadores de suscetibilidade em carcinomas de vias aerodigestivas superiores. [Biomarkers of susceptibility in upper aerodigestive system cancer]. São Paulo, 2003. 78 p. Tese(Doutorado)-Fundação Antonio Prudente. Disponível em: http://accamargo.phlnet.com.br/Doutorado/2003/us84.pdf NEOPLASIAS DO TRATO AERODIGESTIVO SUPERIOR. EPIDEMIOLOGIA; NEOPLASIAS DO TRATO AERODIGESTIVO SUPERIOR. GENETICA; MARCADORES GENETICOS; POLIMORFISMO. GENETICA; FATORES DE RISCO |
| 2/170 | US=70 / Câncer Rossi BM. Comentário de artigo: detecção de câncer de bexiga através de biomarcadores. In: Santos EMM, Rossi BM. Câncer hereditário: atualização. São Paulo: Lemar, 2006. p. 205. |
| 3/170 | US=19 / Psco/Psq Cinciripini PM, Gritz ER, Tsoh JY, Skaar KL. Smoking cessation and cancer prevention. In: Holland JC. Psycho-oncology. New York: Oxford University, 1998. p. 27-44. EXTENSAO DO PROBLEMA; CANCER; PREVENCAO; CESSACAO; FUMO; FATORES DE RISCO; CARCINOGENESIS; BIOMARCADORES; RADIOTERAPIA; CHEMOTHERAPY; RECOMENDACOES; NICOTINA; PACIENTES |
| 4/170 | US=22 / Câncer Liotta LA, Belluco C, Petricoin III EF. Genomics and proteomics. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 13-34. MEDICINA MOLECULAR; MICROARRAYS; CANCER HUMANO; BIOINFORMATICA; MICRODISSECCAO; TERAPIAS COMBINADAS; DETECCAO DO CANCER; BIOMARCADORES; NANOTECNOLOGIA E MEDICINA; PROTEOMICA |
| 5/170 | US=22 / Câncer Hecht SS. Etiology of cancer: tobacco. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 147-55. EPIDEMIOLOGIA DO TABACO E CANCER; CARCINOGENESIS E TABACO; CANCER CAUSADO PELO TABACO; MECANISMOS DO TUMOR INDUZIDO PRODUTOS DO TABACO; BIOMARCADORES/CARCINOGENESIS/TABACO |
| 6/170 | US=22 / Câncer Brenner DE. Cancer prevention: chemoprevention - principles of cancer chemoprevention. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 609-15. PREVENCAO DO CANCER; DEFINICAO DA QUIMIOPREVENCAO; INTERVENCAO/IDENTIFICACAO; TRANSFORMACAO CELULAR; CARCINOGENESIS; BIOMARCADORES MOLECULARES; TUMOR SUPRESSOR/HIPERSENSIBILIDADE; DESENVOLVIMENTO DA POPULACAO BASE; ENSAIOS BIOQUIMICOS; MODELO EFICACIO IN VITRO |
| 7/170 | US=22 / Câncer Hayes DF. Biomarkers. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 774-80. |
| 8/170 | US=48 / Biol/Mol Tainsky MA. Tumor biomarker discovery: methods and protocols. New Jersey: Humana Press, 2009. 332 p. (Methods in Molecular Biology 520). ISBN 978-1-60327-810-2. |
| 9/170 | US=2 / Mama Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. 341 p. (Cancer Drug Discovery and Development). ISBN 978-1-58829-227-4. CANCER DE MAMA; BIOMARCADORES; DIAGNOSTICO MOLECULAR; PROGNOSTICO; MARCADORES TUMORAIS |
| 10/170 | US=1 / Gastro Marrero JA. Screening and biomarkers for hepatocellular carcinoma. In: Carr BI. Hepatocellular carcinoma: diagnosis and treatment. New York: Humana Press, 2010. p. 327-48. ISBN 978-1-60327-373-2. BIOMARCADORES PARA O CARCINOMA HEPATOCELULAR; CARCINOMA HEPATOCELULAR; NOVOS BIOMARCADORES |
| 11/170 | US=23-F / Câncer Cho WCS. Cancer biomarkers (an overview). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 21-40. ISBN 978-90-481-3185-3. |
| 12/170 | US=26-A / Radioterapia Ang KK. Advances in the treatment of head and neck cancer. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 161-8. ISBN 978-0-323-04971-9. CANCER DE CABECA E PESCOCO; RADIOTERAPIA; QUIMIOTERAPIA; BIOMARCADORES MOLECULARES |
| 13/170 | US=23-F / Câncer Zhou X, Yu T, Wong DT. Quantitative reverse transcription - polymerase chain reaction based assessment of the canadidate biomarkers for tongue cancer metastasis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods, overviews, head and neck cancer, and thyroid cancer. New York: Springer, 2010. p. 285-302. ISBN 978-90-481-3185-3. BIOMARCADORES CANADIDATE; CANCER DA LINGUA; TRANSCRICAO REVERSA QUANTITATIVA |
| 14/170 | US=3 / Nutrição Baxter YC, Waitzberg DL, Peres G. Biomarcadores dietéticos e medida da qualidade de vida. In: Waitzberg DL. Nutrição oral, enteral e parenteral na prática clínica. 4ªed. São Paulo: Atheneu, 2009. p. 457-71. ISBN 85-3880045-3. BIOMARCADORES DIETETICOS; MEDIDA DA QUALIDADE DE VIDA; INDICADORES DIETETICOS; DIETETICO-NUTRICIONAL; QUALIDADE DE VIDA |
| 15/170 | US=9 / Quimioterapia Wagner KH, Misík M, Nersesyan A, Knasmüller S. Methods to determine total antioxidative capacity and oxidative DNA damage. In: Knasmüller S, DeMarini DM, Johnson I, Gerhäuser C. Chemoprevention of cancer and DNA damage by dietary factors. Weinheim: Wiley-VCH, 2009. p. 229-44. ISBN 978-3-527-32058-5. CAPACIDADE ANTIOXIDANTE TOTAL; DANO OXIDATIVO AO DNA; OXIDACAO DE MACROMOLECULAS; BIOMARCADORES DE OXIDACAO LIPIDICA; BIOMARCADORES DE OXIDACAO DE PROTEINAS |
| 16/170 | US=27 / Clin/Médica Barker AD. Biomarcadores de câncer. In: Goldman L, Ausiello D, editors. Cecil medicina. 23ª ed. Rio de Janeiro: Elsevier, 2009. p. 1566-71. ISBN 85-3523677-4. CANCER; BIOMARCADORES; CANCER DE MAMA; CANCER COLORRETAL; LINFOMA; CANCER DE OVARIO; CANCER DE PROSTATA |
| 17/170 | US=35 / Gastro Smith RC. Novel biomarkers for biliary tract cancer. In: Thomas CR Junior, Fuller CD. Biliary tract and gallbladder cancer: diagnosis and therapy. New Jersey: DemosMedical, 2009. p. 65-76. ISBN 978-1-933864-42-6. CANCER DO TRATO BILIAR; BIOMARCADORES; COLANGIOCARCINOMA; P53; ATIVADOR DE PLASMINOGENIO UROQUINASE; INIBIDOR DO ATIVADOR DO PLASMINOGENIO TIPO 2; ANALISE PROTEOMICA DA BILE |
| 18/170 | US=37 / Biol/Mol Maxwell P, Ibrahim M. Immunocytochemistry. In: Hannon-Fletcher M, Maxwell P. Advanced techniques in diagnostic cellular pathology. New Jersey: John Wiley & Sons, 2009. p. 99-134. ISBN 978-0-470-51597-6. IMUNOCITOQUIMICA; GARANTIA DE QUALIDADE; IMUNOCITOQUIMICA METODOS DE PONTUACAO; IMUNOCITOQUIMICA CLINICA; LINFOMA FOLICULAR; ANGIOGENESE; CICLO CELULAR; BIOMARCADORES PREDITIVOS DE RESPOSTA A TERAPIA |
| 19/170 | US=39 / Patologia Snoj N, Dinh P, Bedard P, Sotiriou C. Molecular biology of breast cancer. In: Coleman WB, Tsongalis GJ. Molecular pathology: the molecular basis of human disease. Amsterdam: Elsevier, 2009. p. 501-17. ISBN 978-0-12-374419-7. CANCER DE MAMA; BIOLOGIA MOLECULAR; BIOMARCADORES; EXPRESSAO GENICA |
| 20/170 | US=44 / Biol/Mol Pardee AB, Liang P. Cancer detection and biomarkers. In: Pardee AB, Stein GS, editors. The biology and treatment of cancer: understanding cancer. New Jersey: John Wiley & Sons, 2009. p. 145-54. ISBN 978-0-470-00958-1. DETECCAO DE CANCER; BIOMARCADORES NO CANCER; DETECCAO COM BIOMARCADORES; DNA; RNA MENSAGEIRO; AMOSTRAGEM; DETECCAO PRECOCE CANCER |
